Colon Adenocarcinoma — Trials

Colon Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

132 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 15
Ph III recruiting: 2
Growth YoY: —
Industry share: 11%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03592641	Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer	terminated	Phase 2	5	National Cancer Institute (NCI)NIH	1	Oct 17, 2023	clinicaltrials
NCT03693846	Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors	terminated	Phase 2	11	Abramson Cancer Center at Penn MedicineOTHER	1	Oct 20, 2022	clinicaltrials